Tirzepatide

Tirzepatide activates GLP-1 and GIP receptor pathways, allowing researchers to examine molecular mechanisms of glucose homeostasis, insulin signaling, and metabolic regulation. Each 5 mg vial of lyophilized Tirzepatide is supplied with ≥99% purity, providing consistent and reproducible results for advanced metabolic and molecular research applications.

Key Features:

• Dual agonist peptide for GLP-1 and GIP receptor research
• Supports studies on glucose metabolism, insulin signaling, and energy balance
• High-purity (≥99%), batch-verified
• Lyophilized powder, 5 mg per vial
• Designed exclusively for laboratory research

Applications in Research:

• Investigating GLP-1 and GIP receptor signaling pathways
• Studying insulin secretion and glucose regulation in vitro
• Exploring molecular mechanisms of metabolic homeostasis

Important Notice:
THIS PRODUCT IS NOT INTENDED FOR HUMAN OR ANIMAL CONSUMPTION. USE ONLY IN PROPERLY CONTROLLED LABORATORY SETTINGS.